Radice Law Firm is one of class counsel for direct purchaser plaintiffs in an antitrust action alleging an unlawful scheme to monopolize the market for cholesterol medication Niaspan. The case is pending in the federal district court in the Eastern District of Pennsylvania and is in discovery.